↓ Skip to main content

Wiley Online Library

Impact of Medicaid disenrollment in Tennessee on breast cancer stage at diagnosis and treatment

Overview of attention for article published in Cancer (0008543X), June 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
28 news outlets
blogs
3 blogs
twitter
78 tweeters
facebook
2 Facebook pages
googleplus
1 Google+ user

Readers on

mendeley
5 Mendeley
Title
Impact of Medicaid disenrollment in Tennessee on breast cancer stage at diagnosis and treatment
Published in
Cancer (0008543X), June 2017
DOI 10.1002/cncr.30771
Pubmed ID
Authors

Tarazi, Wafa W., Bradley, Cathy J., Bear, Harry D., Harless, David W., Sabik, Lindsay M., Wafa W. Tarazi, Cathy J. Bradley, Harry D. Bear, David W. Harless, Lindsay M. Sabik

Abstract

States routinely may consider rollbacks of Medicaid expansions to address statewide economic conditions. To the authors' knowledge, little is known regarding the effects of public insurance contractions on health outcomes. The current study examined the effects of the 2005 Medicaid disenrollment in Tennessee on breast cancer stage at the time of diagnosis and delays in treatment among nonelderly women. The authors used Tennessee Cancer Registry data from 2002 through 2008 and estimated a difference-in-difference model comparing women diagnosed with breast cancer who lived in low-income zip codes (and therefore were more likely to be subject to disenrollment) with a similar group of women who lived in high-income zip codes before and after the 2005 Medicaid disenrollment. The study outcomes were changes in stage of disease at the time of diagnosis and delays in treatment of >60 days and >90 days. Overall, nonelderly women in Tennessee were diagnosed at later stages of disease and experienced more delays in treatment in the period after disenrollment. Disenrollment was found to be associated with a 3.3-percentage point increase in late stage of disease at the time of diagnosis (P = .024), a 1.9-percentage point decrease in having a delay of >60 days in surgery (P = .024), and a 1.4-percentage point decrease in having a delay of >90 days in treatment (P = .054) for women living in low-income zip codes compared with women residing in high-income zip codes. The results of the current study indicate that Medicaid disenrollment is associated with a later stage of disease at the time of breast cancer diagnosis, thereby providing evidence of the potential negative health impacts of Medicaid contractions. Cancer 2017. © 2017 American Cancer Society.

Twitter Demographics

The data shown below were collected from the profiles of 78 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 5 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 20%
Student > Master 1 20%
Student > Ph. D. Student 1 20%
Student > Doctoral Student 1 20%
Professor > Associate Professor 1 20%
Other 0 0%
Readers by discipline Count As %
Unspecified 2 40%
Nursing and Health Professions 1 20%
Economics, Econometrics and Finance 1 20%
Medicine and Dentistry 1 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 278. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 September 2017.
All research outputs
#24,921
of 8,641,127 outputs
Outputs from Cancer (0008543X)
#54
of 5,989 outputs
Outputs of similar age
#1,821
of 246,675 outputs
Outputs of similar age from Cancer (0008543X)
#5
of 149 outputs
Altmetric has tracked 8,641,127 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,989 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 246,675 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 149 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.